BIONTECH SE - AMERICAN DEPOSITARY SHARES

BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda

18 дек 2023 12:15:00 Источник Nasdaq GlobeNewswire

BioNTech to Inaugurate First African Site on December 18, 2023

12 дек 2023 05:45:00 Источник Nasdaq GlobeNewswire

BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update

06 ноя 2023 05:45:00 Источник Nasdaq GlobeNewswire

Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19

26 окт 2023 05:45:00 Источник Nasdaq GlobeNewswire

BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023

23 окт 2023 10:30:00 Источник Nasdaq GlobeNewswire

BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to Host Innovation Series Day on November 7, 2023

23 окт 2023 05:45:00 Источник Nasdaq GlobeNewswire

BioNTech Expands Late-Stage Clinical Oncology Portfolio with Initiation of further Phase 2 Trial with mRNA-based Individualized Neoantigen Specific Immunotherapy in New Cancer Indication

19 окт 2023 05:45:00 Источник Nasdaq GlobeNewswire

BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023

16 окт 2023 02:30:00 Источник Nasdaq GlobeNewswire

Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs

16 окт 2023 02:00:00 Источник Nasdaq GlobeNewswire

Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine

28 сен 2023 11:24:00 Источник Nasdaq GlobeNewswire

BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission

18 сен 2023 05:45:00 Источник Nasdaq GlobeNewswire

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union

30 авг 2023 09:00:00 Источник Nasdaq GlobeNewswire

BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer

14 авг 2023 05:45:00 Источник Nasdaq GlobeNewswire

BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update

07 авг 2023 05:00:00 Источник Nasdaq GlobeNewswire

BioNTech Completes Acquisition of InstaDeep

31 июл 2023 07:00:00 Источник Nasdaq GlobeNewswire

BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC

29 июн 2023 05:45:00 Источник Nasdaq GlobeNewswire

BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO

02 июн 2023 05:45:00 Источник Nasdaq GlobeNewswire

BioNTech Announces First Quarter 2023 Financial Results and Corporate Update

08 май 2023 05:45:00 Источник Nasdaq GlobeNewswire

BioNTech to Report First Quarter 2023 Financial Results and Operational Update on May 8, 2023

24 апр 2023 05:45:00 Источник Nasdaq GlobeNewswire

BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors

03 апр 2023 05:45:00 Источник Nasdaq GlobeNewswire